Quick Answer
Tanke Biosciences Corp reported Diluted EPS of $0.24 per share (loss) for fiscal year 2011.
Tanke Biosciences Corp Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2011 | -$0.24 | -170.6% |
| 2010 | $0.34 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2012 | $0.07 | +163.6% | +240.0% |
| March 31, 2012 | -$0.05 | +70.6% | +54.5% |
| September 30, 2011 | -$0.11 | — | +35.3% |
| March 31, 2011 | -$0.17 | — | — |
- Tanke Biosciences Corp showed a decrease of -170.6% in Diluted EPS compared to the prior fiscal year.
- Over the 2010–2011 period, Tanke Biosciences Corp’s diluted eps has declined by 170.6% (from $0.34 per share to $0.24 per share (loss)).
- The most recent figure is from Tanke Biosciences Corp’s fiscal year 2011 report (Form 10-K), filed with the SEC on April 16, 2012.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: